GLP-1 receptor agonist drugs as a protective factor against chronic kidney disease in patients with type 2 diabetes mellitus. RSD [Internet]. 2021 Dec. 10 [cited 2025 Dec. 5];10(16):e134101623517. Available from: https://rsdjournal.org/rsd/article/view/23517